fbpx Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science over the past two weeks.

Daré Inks Deal with Bayer; Gilead Backs Kyverna; Neurocrine Partners with Idorsia

  • 2020-01-17T20:42:00.000+0000
  • California
  • Author: Lauren Panetta

1/17/20 – Endpoints
Novo Nordisk's blockbuster Ozempic wins FDA label boost with CV indication

1/17/20 – BioSpace
Eli Lilly Plans Spending Spree for 2020

1/16/20 – Arena Pharmaceuticals
FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients

1/16/20 – FierceBiotech
Pfizer teams up with Insilico to mine data for drug targets

1/15/20 – BioSpace
Iovance Biotherapeutics Completes Patient Dosing in Registration-Enabling Cohort 4 of the C-144-01 Melanoma Study with Lifileucel

1/15/20 – GEN
Synthego Adopts GMP Standards for Producing sgRNA

1/15/20 – Tandem Diabetes
Tandem Diabetes Care Announces Commercial Launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States

1/14/20 – Xconomy
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive

1/14/20 – BioSpace
Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

1/14/20 – San Diego Union-Tribune
Dexcom teams with Livongo Health to help diabetics better manage the disease

1/14/20 – BioSpace
Roche Plans to Undercut SMA Therapy Price to Compete with Biogen and Novartis

1/14/20 – FierceBiotech
Astellas teams with Adaptimmune to create CAR-T, TCR therapies

1/14/20 – BioSpace
Gilead Backs Startup Kyverna Therapeutics with Financing, Collaborative Agreement

1/13/20 – Xconomy
NeoGenomics Nabs Human Longevity’s Oncology Division for $37M

1/13/20 – GEN
Argonaut Launches Aseptic Drug Product Manufacturing Services

1/13/20 – FierceBiotech
Roche, Illumina unveil 15-year cancer diagnostic tie-up

1/12/20 – FierceBiotech
ArcherDX expands co-marketing, IVD partnerships with Illumina

1/11/20 – Xconomy
Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia

1/10/20 – FierceBiotech
Inflammatix raises $32M for its point-of-care infection test

1/10/20 – BridgeBio Pharma
BridgeBio Pharma’s Gene Therapy Subsidiaries Enter Strategic Partnership with Catalent for Dedicated Gene Therapy Development and Manufacturing Capacity

1/10/20 – FierceBiotech
Tyra banks $50M to attack treatment-resistant tumors

1/10/20 – Ionis Pharma
Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid Cardiomyopathy

1/10/20 – FierceBiotech
DNA sequencing hardware startup Omniome raises $60M

1/10/20 Cidara Therapeutics
Cidara Therapeutics Announces Proposed Rights Offering

1/9/20 – Xconomy
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs

1/9/20 – Abilita Bio
Abilita Bio Announces Business Growth and Key Developments

1/9/20 – FierceBiotech
Boehringer buys Enleofen IL-11 platform to boost NASH pipeline

1/4/20 – San Diego Union-Tribune
Now building: $164M life science campus in Torrey Pines

1/3/20 – FierceBiotech
New year, new name, new CEO for synthetic biology co. Intrexon